Advanced solution designed for smoother transition from invasive to
noninvasive ventilation
Company Website:
http://www.philips.ca
MARKHAM, ON, Canada -- (Business Wire)
Royal
Philips (NYSE: PHG, AEX: PHIA) today announced the Canadian launch
of the Philips
Respironics V680 Ventilator for hospital respiratory care, offering
both invasive and noninvasive ventilation. The Philips Respironics V680
Ventilator was recently unveiled at the Canadian Society of Respiratory
Therapists’ Annual Conference in Calgary, Alberta.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20150529005102/en/
Discover Philips Respironics V680, the simple, clinically advanced way to provide your patients with reliable, high-performance ventilation across the continuum of care. (Photo: Business Wire)
In consultation with clinicians, the Philips Respironics V680 Ventilator
is designed for smoother transition from ventilation to natural
breathing, which may help enhance patient care. The Philips Respironics
V680 Ventilator joins Philips’ existing portfolio of leading edge
patient-centred hospital respiratory care solutions, created to deliver
higher quality and comfortable care.
“For nearly 125 years, Philips has been committed to delivering
innovations that improve people’s lives. The Philips Respironics V680
Ventilator is yet another example of Philips technology that is designed
with the needs of both the patient and clinician in mind,” said Iain
Burns, President, Philips Canada. “From Healthy Living, Prevention,
Diagnosis, to Treatment, Recovery and Home Care, Philips creates
solutions that span the health continuum, and it’s how we are delivering
on our vision to make the world healthier through innovation.”
The Philips Respironics V680 Ventilator is the first ventilator to
combine the Philips gold standard single-limb noninvasive ventilation
(NIV) solution with a fully featured, dual-limb system. Designed to
deliver advanced life support for critically ill patients in the
Intensive Care Unit (ICU), the Philips Respironics V680 Ventilator is
also designed to make it fast and easy to switch from invasive to
noninvasive ventilation to streamline transitions. Personalized to each
patient, the Philips Respironics V680 Ventilator can help deliver the
right therapy at the right time. The Philips Respironics V680 Ventilator
is the only ventilator to provide continuous measurements of dynamic
resistance, compliance, elastance, and plateau pressure in both single
and dual-limb invasive and noninvasive modes.
“Noninvasive therapy has become the first line of therapy for many
patients presenting with respiratory distress,” commented Thomas
Piraino, RRT, FCSRT, Best Practice Clinical Educator and Assistant
Clinical Professor (Adjunct) for McMaster University. “In my
opinion, the BiPAP Vision, and the current V60 have always been the gold
standard for the noninvasive treatment of acute respiratory distress.
The ability to deliver invasive mechanical ventilation for the patient
unable to improve, or be managed with noninvasive therapy is what makes
the V680 ventilator a compelling product for critical care and emergency
departments, or as a primary mechanical ventilator in the community
hospital setting.”
NIV has become a standard of care for the management of acute
respiratory failure, but there is a risk of leaks around the mask that
may interfere with ventilator performance. As a result,
patient-ventilator asynchrony, defined as a mismatch between patient's
inspiratory time and the ventilator insufflation time, may occur in
nearly 25 per cent of intubated patients.1 These high rates
of asynchrony can be associated with a higher incidence of weaning
failure and tracheostomy, prolonged mechanical ventilation, fatigue,
increased sedation needs and longer hospital stays.1
A recent study to compare patient-ventilator synchrony during NIV
between ICU, transport and dedicated NIV ventilators, found the use of a
NIV ventilator on critically ill patients led to a significant decrease
in the incidence of patient-ventilator asynchrony.2 Moreover,
dedicated NIV ventilators exhibited more standardised behaviour during
the investigation, with an ability to avoid auto-triggering or delayed
cycling while keeping a short triggering delay despite the presence of
leaks.2
The Philips Respironics V680 Ventilator joins Philips’ existing
portfolio of patient-centred hospital respiratory care solutions which
includes the Philips Respironics V60; the Philips gold standard hospital
dedicated noninvasive ventilator.
The Philips Respironics V680 Ventilator is now available in Canada and
several European markets. US launch is pending 510(k) clearance.
For more information on the Philips Respironics V680 Critical Care
Ventilator please visit: http://www.philips.ca/healthcare-product/HCNOCTN323/respironics-v680
and follow the conversation on Twitter @PhilipsHealth.
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is
a diversified health and well-being company, focused on improving
people’s lives through meaningful innovation in the areas of Healthcare,
Consumer Lifestyle and Lighting. Headquartered in the Netherlands,
Philips posted 2014 sales of EUR 21.4 billion and employs approximately
108,000 employees with sales and services in more than 100 countries.
The company is a leader in cardiac care, acute care and home healthcare,
energy efficient lighting solutions and new lighting applications, as
well as male shaving and grooming and oral healthcare. News from Philips
is located at www.philips.com/newscenter.
References:
1 Bitando et al. Patient-ventilator asynchrony during
conventional or automated pressure support ventilation in
difficult-to-wean patients. Critical Care 2012, 16(Suppl 1):P126
2
Carteaux et al. Patient-Ventilator Asynchrony During Noninvasive
Ventilitation. Chest 2012; 142(2): p. 367-376.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150529005102/en/
Contacts:
Philips Canada
Santina Giuliano, +1 905-201-4196
santina.giuliano@philips.com
Source: Royal Philips
© 2024 Canjex Publishing Ltd. All rights reserved.